These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32269201)

  • 1. Effect of the Creatinine Excretion Rate Index, a Marker of Sarcopenia, on Prediction of Intracranial Hemorrhage in Patients With Advanced Heart Failure and a Continuous-Flow Left Ventricular Assist Device.
    Iwasaki K; Seguchi O; Murata S; Nishimura K; Yoshitake K; Yagi N; Sujino Y; Anegawa E; Mochizuki H; Kuroda K; Nakajima S; Watanabe T; Yanase M; Fukushima S; Fujita T; Kobayashi J; Ito H; Fukushima N
    Circ J; 2020 May; 84(6):949-957. PubMed ID: 32269201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage.
    Ibeh C; Tirschwell DL; Mahr C; Creutzfeldt CJ
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106053. PubMed ID: 34418673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
    Carroll AH; Ramirez MP; Dowlati E; Mueller KB; Borazjani A; Chang JJ; Felbaum DR
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105501. PubMed ID: 33271486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure and adverse events during continuous flow left ventricular assist device support.
    Saeed O; Jermyn R; Kargoli F; Madan S; Mannem S; Gunda S; Nucci C; Farooqui S; Hassan S; Mclarty A; Bloom M; Zolty R; Shin J; D'Alessandro D; Goldstein DJ; Patel SR
    Circ Heart Fail; 2015 May; 8(3):551-6. PubMed ID: 25870369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of acute kidney injury after left ventricular assist device implantation: Evaluation of clinical risk scores.
    Pilarczyk K; Carstens H; Papathanasiou M; Luedike P; Koch A; Jakob H; Kamler M; Pizanis N
    Artif Organs; 2020 Feb; 44(2):162-173. PubMed ID: 31361341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.
    Birati EY; Hanff TC; Maldonado D; Grandin EW; Kennel PJ; Mazurek JA; Vorovich E; Seigerman M; Howard JLL; Acker MA; Naka Y; Wald J; Goldberg LR; Jessup M; Atluri P; Margulies KB; Schulze PC; Rame JE
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
    Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
    Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure.
    ter Maaten JM; Damman K; Hillege HL; Bakker SJ; Anker SD; Navis G; Voors AA
    Clin Res Cardiol; 2014 Dec; 103(12):976-83. PubMed ID: 24990450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation.
    Petroni T; D'Alessandro C; Combes A; Golmard JL; Brechot N; Barreda E; Laali M; Farahmand P; Varnous S; Weber P; Pavie A; Leprince P
    Arch Cardiovasc Dis; 2019; 112(8-9):485-493. PubMed ID: 31353279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience.
    Sugiura T; Kurihara C; Kawabori M; Critsinelis AC; Wang S; Civitello AB; Rosengart TK; Frazier OH; Morgan JA
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1083-1089.e1. PubMed ID: 30904255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival.
    Brewer RJ; Cabrera R; El-Atrache M; Zafar A; Hrobowski TN; Nemeh HM; Selektor Y; Paone G; Williams CT; Velez M; Tita C; Morgan JA; Lanfear DE
    Int J Artif Organs; 2014 Nov; 37(11):834-8. PubMed ID: 25450319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.